Furthermore, overexpression of EGFR (or HER2/ERRB2) is not characteristic for the majority of tumour samples obtained from HNSCC patients [133], and EGFR downstream activity in tumour tissues is significantly below the levels observed in HNSCC cell lines. This evidence concerns the gene ESRRB and head and neck squamous cell carcinoma.